Bayesian Capital Management’s Trueblue TBI Stock Holding History
Bought
Maintained
Sold
Other funds holding TBI
GC
ACH
Bayesian Capital Management's TBI Position: Q1 2018 in Review
Bayesian Capital Management sold out of Trueblue (TBI) in Q1 2018, closing a stake of 8,420 shares — an estimated $232K sold.
Bayesian Capital Management first reported a position in TBI in Q4 2015 and held it in 4 quarters. The position peaked at $243K in Q3 2016. 196 funds tracked by Wall St. Rank hold TBI as of Q1 2018.
- Bayesian Capital Management reported no remaining Trueblue position as of Q1 2018 after selling out during the quarter.
- Bayesian Capital Management sold 8,420 Trueblue shares in Q1 2018, an estimated $232K.
- Bayesian Capital Management first reported a position in Trueblue in Q4 2015 and held it in 4 quarters.
- Bayesian Capital Management's Trueblue position peaked at $243K in Q3 2016.
- 196 funds tracked by Wall St. Rank held Trueblue as of Q1 2018.
Based on Bayesian Capital Management's 13F filing for Q1 2018, filed 15 May 2018.